Conyers provided Cayman Islands and British Virgin Islands legal advice to JBM (Healthcare) Limited (“JBM”) in connection with its HK$53.6 million initial public offering of 44,686,000 shares on the Main Board of The Stock Exchange of Hong Kong (Stock code: 2161).

JBM is a spun off from its parent, Jacobson Pharma Corporation Limited, another Main Board listed company (Stock code: 2633). Based in Hong Kong, JBM develops, markets and distributes branded healthcare products.

Partner Anna Chong and Associate Charissa Ball of Conyers’ Hong Kong office advised on the matter working alongside Norton Rose Fulbright.

Stay current with our latest legal insights and subscribe today